机译:雄激素受体表达在可手术三阴性乳腺癌中的预后价值:基于组织芯片的回顾性分析
State Key Laboratory of Oncology in South China, 510060, Guangzhou, People’s Republic of China;
State Key Laboratory of Oncology in South China, 510060, Guangzhou, People’s Republic of China;
State Key Laboratory of Oncology in South China, 510060, Guangzhou, People’s Republic of China;
State Key Laboratory of Oncology in South China, 510060, Guangzhou, People’s Republic of China;
Department of Medical Oncology, Zhongshan City Pepole’s Hospital, 528403, Zhongshan, People’s Republic of China;
Department of Medical Oncology, Zhongshan City Pepole’s Hospital, 528403, Zhongshan, People’s Republic of China;
Department of Medical Oncology, Zhongshan City Pepole’s Hospital, 528403, Zhongshan, People’s Republic of China;
State Key Laboratory of Oncology in South China, 510060, Guangzhou, People’s Republic of China;
Breast carcinoma; Triple-negative; Androgen receptor; Prognosis; Tissue microarrays;
机译:在可手术的三阴性乳腺癌中雄激素受体表达的预后价值:基于组织芯片的回顾性分析。
机译:绝经后女性肿瘤组织中雄激素受体的表达水平及其在原发性可手术管腔型乳腺癌中的表达及预后意义
机译:EGFR表达与三阴性乳腺癌的无病生存期降低相关:基于组织芯片的回顾性分析
机译:基于亚组统计方法的乳腺癌微阵列数据差异基因表达分析
机译:自然杀伤细胞受体对三重阴性乳腺癌细胞的表达和功能
机译:雄激素受体表达在三阴性乳腺癌中的预后价值:个人经验和Collignon等对三阴性乳腺癌:治疗挑战和解决方案的评论
机译:肿瘤组织中雄激素受体的表达水平及其在绝经后妇女的初级可操作腔乳腺癌中的预后显着性